These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 12709722

  • 1. Effect of itraconazole on the pharmacokinetics of rosuvastatin.
    Cooper KJ, Martin PD, Dane AL, Warwick MJ, Schneck DW, Cantarini MV.
    Clin Pharmacol Ther; 2003 Apr; 73(4):322-9. PubMed ID: 12709722
    [Abstract] [Full Text] [Related]

  • 2. The effect of erythromycin on the pharmacokinetics of rosuvastatin.
    Cooper KJ, Martin PD, Dane AL, Warwick MJ, Raza A, Schneck DW.
    Eur J Clin Pharmacol; 2003 May; 59(1):51-6. PubMed ID: 12682802
    [Abstract] [Full Text] [Related]

  • 3. Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects.
    Cooper KJ, Martin PD, Dane AL, Warwick MJ, Raza A, Schneck DW.
    Br J Clin Pharmacol; 2003 Jan; 55(1):94-9. PubMed ID: 12534645
    [Abstract] [Full Text] [Related]

  • 4. The effect of fluconazole on the pharmacokinetics of rosuvastatin.
    Cooper KJ, Martin PD, Dane AL, Warwick MJ, Schneck DW, Cantarini MV.
    Eur J Clin Pharmacol; 2002 Nov; 58(8):527-31. PubMed ID: 12451430
    [Abstract] [Full Text] [Related]

  • 5. An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers.
    Martin PD, Dane AL, Schneck DW, Warwick MJ.
    Clin Ther; 2003 Feb; 25(2):459-71. PubMed ID: 12749507
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.
    Martin PD, Warwick MJ, Dane AL, Cantarini MV.
    Clin Ther; 2003 Aug; 25(8):2215-24. PubMed ID: 14512129
    [Abstract] [Full Text] [Related]

  • 7. No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers.
    Martin PD, Kemp J, Dane AL, Warwick MJ, Schneck DW.
    J Clin Pharmacol; 2002 Dec; 42(12):1352-7. PubMed ID: 12463730
    [Abstract] [Full Text] [Related]

  • 8. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
    Schneck DW, Birmingham BK, Zalikowski JA, Mitchell PD, Wang Y, Martin PD, Lasseter KC, Brown CD, Windass AS, Raza A.
    Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
    [Abstract] [Full Text] [Related]

  • 9. Effect of itraconazole on the pharmacokinetics of atorvastatin.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Jul; 64(1):58-65. PubMed ID: 9695720
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.
    Martin PD, Mitchell PD, Schneck DW.
    Br J Clin Pharmacol; 2002 Nov; 54(5):472-7. PubMed ID: 12445025
    [Abstract] [Full Text] [Related]

  • 11. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
    Martin PD, Warwick MJ, Dane AL, Brindley C, Short T.
    Clin Ther; 2003 Oct; 25(10):2553-63. PubMed ID: 14667956
    [Abstract] [Full Text] [Related]

  • 12. The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics.
    Martin PD, Schneck DW, Dane AL, Warwick MJ.
    Curr Med Res Opin; 2008 Apr; 24(4):1231-5. PubMed ID: 18355422
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study.
    Zhang W, Deng S, Chen XP, Zhou G, Xie HT, He FY, Cao D, Li YJ, Zhou HH.
    Clin Ther; 2008 Jul; 30(7):1283-9. PubMed ID: 18691987
    [Abstract] [Full Text] [Related]

  • 14. Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.
    Martin PD, Warwick MJ, Dane AL, Hill SJ, Giles PB, Phillips PJ, Lenz E.
    Clin Ther; 2003 Nov; 25(11):2822-35. PubMed ID: 14693307
    [Abstract] [Full Text] [Related]

  • 15. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ, Kantola T, Kivistö KT.
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [Abstract] [Full Text] [Related]

  • 16. No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor.
    Martin PD, Dane AL, Nwose OM, Schneck DW, Warwick MJ.
    J Clin Pharmacol; 2002 Oct; 42(10):1116-21. PubMed ID: 12362926
    [Abstract] [Full Text] [Related]

  • 17. Effect of itraconazole on cerivastatin pharmacokinetics.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Eur J Clin Pharmacol; 1999 Jan; 54(11):851-5. PubMed ID: 10027660
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG, Martin PD, Mitchell PD, Lasseter K, Gibson G, Schneck DW.
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat.
    Nezasa K, Takao A, Kimura K, Takaichi M, Inazawa K, Koike M.
    Xenobiotica; 2002 Aug; 32(8):715-27. PubMed ID: 12296991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.